Dexmedetomidine on Prevention of Side Effects of Hemabate

• Status: Unknown status
• Trial end date: 2014-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

Hemabate is often used for gynecological patients. Hemabate is associated with many side effects, including a burning sensation in the stomach, nausea, vomiting, diarrhea etc. It is reported that dexmedetomidine reduce gastrointestinal reaction during perioperative period. We design this clinical trial to find if dexmedetomidine can prevent the side effects of hemabate in Cesarean Section patients.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Jin Ni
• Treatments: Carboprost; Carboprost tromethamine; Dexmedetomidine

Criteria

Inclusion Criteria:

gynecological patients

Exclusion Criteria:

• Neuromuscular and endocrine diseases

• Allergic reactions to a2-adrenergic agonist

• Previous abdominal surgery including prior caesarean section.